PROFIL GANGGUAN
NEUROKOGNITIF PADA
PENDERITA PENYAKIT PARKINSON DI RUMAH SAKIT
RUJUKAN DI KOTA DENPASAR TAHUN 2018
Putri Eka Pradnyaning1, Ketut Widyastuti1, Anak Agung Ayu Putri Laksmidewi1, Sri Yenni
Trisnawati1, Dewa Putu Gede Purwa Samatra1, I Ketut Sumada2
1
Departemen Neurologi, FK Universitas Udayana/RSUP Sanglah Denpasar, Bali, Indonesia
2
Departemen Neurologi RSUD Wangaya Denpasar, Bali, Indonesia
ABSTRAK
Latar belakang: Fungsi kognitif merupakan aktivitas terbanyak pada laki-laki (72.3%), usia ≥60 tahun
mental yang dilakukan secara sadar dan gangguannya (63.8%), pendidikan perguruan tinggi atau sederajat
dapat diukur secara objektif menggunakan alat (44.7%), dan pensiunan (21.3%). Sebagian besar
diagnosis baku. Gangguan fungsi kognitif memiliki subjek telah menderita PP selama >5 tahun (42.3%),
dampak besar pada kualitas hidup penderita Penyakit stadium Hoehn and Yahr 2 (38.5%), dan gejala
Parkinson (PP), menambah beban pengampu, dan motorik dominan berupa rigiditas bilateral (26.9%).
menambah biaya kesehatan. Tujuan penelitian ini Domain yang terganggu adalah eksekutif (48.9%),
adalah untuk mengetahui prevalensi dan profil memori (46.8%), visuospasial (29.8%), atensi
gangguan neurokognitif penderita PP di rumah sakit (23.4%), dan bahasa (10.6%). Simpulan: Lebih dari
(RS) rujukan Kota Denpasar berdasarkan demografis, setengah penderita PP rawat jalan di RS rujukan Kota
gejala PP, dan domain kognitif yang terganggu. Denpasar mengalami gangguan neurokognitif dengan
Metode: Penelitian ini adalah penelitian deskriptif karakteristik laki-laki, usia lebih dari 60 tahun,
potong lintang terhadap 47 penderita PP rawat jalan di berpendidikan tinggi, dan pensiunan. Gangguan
RS rujukan Kota Denpasar. Hasil: Angka kejadian eksekutif merupakan domain neurokognitif yang
gangguan neurokogitif pada pasien PP di RS rujukan paling banyak didapatkan.
Kota Denpasar sebesar 55.3% dengan distribusi
Kata Kunci: Penyakit Parkinson, gangguan neurokognitif, prevalensi gangguan neurokognitif pada PP
ABSTRACT
Background: Cognitive is a mental activity performed neurocognitive impairment group were male (72.3%),
by human consciously, and the impairment could be ≥60 years old (63.8%), university graduate (44.7%),
evaluated objectively by diagnostic tools. Impaired and retired (21.3%). The subjects were predominantly
cognition has a major impact on quality of life, have PD for more than 5 years (42.3%), Hoehn and
increasing caregiver burden, and health expense in Yahr stage 2 (38.5%), and the dominant motoric
patients with Parkinson Disease (PD). The aim of this symptom was bilateral rigidity (26.9%). Domain
study was to determine the prevalence and profile of disturbed were executive (48.9%), memory (46.8%),
neurocognitive impairments in PD patients in referral visuospatial (29.8%), attention (23.4%), and language
hospitals in Denpasar, based on demographic, PD (10.6%). Conclussion: More than half PD outpatients
symptoms, and impaired cognitive domain. Method: in referral hospital in Denpasar has neurocognitive
This study was a descriptive cross-sectional study impairment. Males, more than 60 years old, university
measured 47 PD outpatients in referral hospitals in graduates, and retired were dominating. Executive
Denpasar. Result: The occurance rate of disturbance was the most neurocognitive disorders
neurocognitive impairment in PD patients in referral found.
hospital in Denpasar was 55.3%, the highest
Daftar Rujukan
1. Jankovic J. Parkinson’s disease: Clinical 4. Akdag B, Telci EA, Cavlak U. Factors
features and diagnosis. J Neurol Neurosurg affecting cognitive function in older adults: A
Psychiatry. 2008;79(4):368–76. turkish sample. Int J Gerontol. 2013.
2. DeMaagd G, Philip A. Parkinson’s Disease 5. Lin CH, Wu RM. Biomarkers of cognitive
and Its Management: Part 1: Disease Entity, decline in Parkinson’s disease. Park Relat
Risk Factors, Pathophysiology, Clinical Disord [Internet]. 2015;21(5):431–43.
Presentation, and Diagnosis. P T [Internet]. Tersedia pada:
2015;40(8):504–32. Tersedia pada: http://dx.doi.org/10.1016/j.parkreldis.2015.0
http://www.ncbi.nlm.nih.gov/pubmed/26236 2.010
139%5Cnhttp://www.pubmedcentral.nih.gov 6. Broeders M, Velseboer DC, de Bie R,
/articlerender.fcgi?artid=PMC4517533 Speelman JD, Muslimovic D, Post B, et al.
3. Yang Y, Tang B, Guo J. Parkinson ’ s Disease Cognitive change in newly-diagnosed
and Cognitive Impairment. 2016;2016. patients with Parkinson’s disease: a 5-year